Propensity of Levofloxacin in current market (Q3, 2019)
Levofloxacin is clinically used for Chronic bronchitis, Acute bacterial sinusitis, Anthrax, Community-acquired pneumonia, Skin and skin structure infections, Nosocomial pneumonia, Urinary tract infections, Complicated skin and skin structure infections, Acute pyelonephritis and Chronic bacterial prostatitis. The trends of using Levofloxacin in the medical practice has been changing over the time.It looks like, doctor's preference for using Levofloxacin appears to be elevated in the recent clinical practice. In the year 2016, around 22% doctors used to prefer Levofloxacin whenever indication for a 4-Quinolone Preparations came-across in clinical management. Presently, approx 23% doctors prefer Levofloxacin for clinical indication; is expected to 26% over the forecast period of 2020 - 2022. A simultaneous changes in the preference is expected for other 4-Quinolone Preparations.In addition, an increased incidence of related diseases are presumed to be the key contributing factors providing a fillip this generic vertical. Increased awareness, availability of drugs by the key companies, rising demand for improved healthcare are some of the major factors.Furthermore, the presence of high unmet clinical needs with regard to treatment issue is the factor propelling the expansion of this vertical. This modality of treatment is expected to gain popularity in the coming years as generic provides better medication compliance.
You might be interested to